Clinical evidence SELECT cardiovascular outcomes SELECT enrolled 17,604 adults aged 45 years with established atherosclerotic cardiovascular disease (prior MI, stroke, or symptomatic peripheral arterial disease) and BMI 27 kg/m, but without diabetes, randomizing them 1:1 to semaglutide 2.4 mg SC weekly (after titration) or placebo on top of standard CV therapies
Given liraglutides mechanism of action causes increased satiety, there may be an increased risk of young children developing eating disorders
Semaglutide is a medication prescribed for the treatment of type 2 diabetes
A 5 mg vial reconstituted with bacteriostatic water yields about 2.5 mg/mL
The program is active in most of Highmarks Medicaid, Commercial employer-based and ACA fully-insured business, and nearly half of self-insured employer group clients use the model
Drought and salt stress tolerance of an Arabidopsis glutathione S -transferase U17 knockout mutant are attributed to the combined effect of glutathione and abscisic acid